Eastwood Bio Medical Canada Stock Analysis
| EBM Stock | CAD 0.75 0.05 6.25% |
Eastwood Bio Medical Canada is overvalued with Real Value of 0.63 and Hype Value of 0.81. The main objective of Eastwood Bio-Medical stock analysis is to determine its intrinsic value, which is an estimate of what Eastwood Bio Medical Canada is worth, separate from its market price. There are two main types of Eastwood Bio-Medical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Eastwood Bio-Medical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Eastwood Bio-Medical's stock to identify patterns and trends that may indicate its future price movements.
The Eastwood Bio-Medical stock is traded in Canada on TSX Venture Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Eastwood Bio-Medical is usually not traded on Canada Day, Civic Holiday, Labour Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day. Eastwood Stock trading window is adjusted to America/Toronto timezone.
Eastwood |
Eastwood Stock Analysis Notes
About 70.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.01. Eastwood Bio Medical had not issued any dividends in recent years. Eastwood Bio-Medical Canada Inc. researches and develops natural health products in North America and Asia. Eastwood Bio-Medical Canada Inc. is a subsidiary of Eastwood Bio-Medical Research Inc. EASTWOOD BIO operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange. To learn more about Eastwood Bio Medical Canada call Youngsoo Kim at 604 247 2100 or check out https://www.eleotin.ca.Eastwood Bio-Medical Quarterly Total Revenue |
|
Eastwood Bio Medical Investment Alerts
| Eastwood Bio Medical is way too risky over 90 days horizon | |
| Eastwood Bio Medical has some characteristics of a very speculative penny stock | |
| Eastwood Bio Medical appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 867.94 K. Net Loss for the year was (546.6 K) with profit before overhead, payroll, taxes, and interest of 902.74 K. | |
| Eastwood Bio Medical Canada has accumulated about 708.26 K in cash with (16.89 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 70.0% of the company shares are held by company insiders |
Eastwood Bio-Medical Thematic Classifications
In addition to having Eastwood Bio-Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | DrugsDrug manufacturing and delivery |
Eastwood Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 51.66 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Eastwood Bio-Medical's market, we take the total number of its shares issued and multiply it by Eastwood Bio-Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Eastwood Profitablity
Eastwood Bio-Medical's profitability indicators refer to fundamental financial ratios that showcase Eastwood Bio-Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Eastwood Bio-Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Eastwood Bio-Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Eastwood Bio-Medical's profitability requires more research than a typical breakdown of Eastwood Bio-Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.74) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.51) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.51. | Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.29) | (1.22) | |
| Return On Capital Employed | 0.39 | 0.29 | |
| Return On Assets | (1.29) | (1.22) | |
| Return On Equity | 0.81 | 0.85 |
Management Efficiency
Eastwood Bio Medical has return on total asset (ROA) of (0.6415) % which means that it has lost $0.6415 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (7.4716) %, meaning that it generated substantial loss on money invested by shareholders. Eastwood Bio-Medical's management efficiency ratios could be used to measure how well Eastwood Bio-Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to climb to 0.85 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (1.22). At this time, Eastwood Bio-Medical's Non Current Assets Total are fairly stable compared to the past year. Asset Turnover is likely to climb to 1.21 in 2024, whereas Total Assets are likely to drop slightly above 418.2 K in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.01) | (0.01) | |
| Tangible Book Value Per Share | (0.01) | (0.01) | |
| Enterprise Value Over EBITDA | (321.22) | (337.28) | |
| Price Book Value Ratio | (217.70) | (206.81) | |
| Enterprise Value Multiple | (321.22) | (337.28) | |
| Price Fair Value | (217.70) | (206.81) | |
| Enterprise Value | 103.2 M | 78.8 M |
Leadership effectiveness at Eastwood Bio Medical Canada is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin (0.51) | Profit Margin (0.74) | Beta 0.277 | Return On Assets (0.64) | Return On Equity (7.47) |
Technical Drivers
As of the 30th of November, Eastwood Bio-Medical shows the Coefficient Of Variation of 972.15, mean deviation of 10.78, and Downside Deviation of 20.35. Eastwood Bio Medical technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Eastwood Bio Medical variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to decide if Eastwood Bio Medical is priced favorably, providing market reflects its regular price of 0.75 per share.Eastwood Bio Medical Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Eastwood Bio-Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Eastwood Bio Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Eastwood Bio-Medical Outstanding Bonds
Eastwood Bio-Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Eastwood Bio Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Eastwood bonds can be classified according to their maturity, which is the date when Eastwood Bio Medical Canada has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Eastwood Bio-Medical Predictive Daily Indicators
Eastwood Bio-Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Eastwood Bio-Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 0.75 | |||
| Day Typical Price | 0.75 | |||
| Price Action Indicator | (0.03) | |||
| Period Momentum Indicator | (0.05) | |||
| Relative Strength Index | 30.87 |
Eastwood Bio-Medical Forecast Models
Eastwood Bio-Medical's time-series forecasting models are one of many Eastwood Bio-Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Eastwood Bio-Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Eastwood Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Eastwood Bio-Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Eastwood shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Eastwood Bio-Medical. By using and applying Eastwood Stock analysis, traders can create a robust methodology for identifying Eastwood entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (1.01) | (1.06) | |
| Operating Profit Margin | (0.52) | (0.55) | |
| Net Loss | (1.01) | (1.06) | |
| Gross Profit Margin | 0.56 | 0.50 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Eastwood Bio-Medical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Additional Tools for Eastwood Stock Analysis
When running Eastwood Bio-Medical's price analysis, check to measure Eastwood Bio-Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio-Medical is operating at the current time. Most of Eastwood Bio-Medical's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio-Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio-Medical's price. Additionally, you may evaluate how the addition of Eastwood Bio-Medical to your portfolios can decrease your overall portfolio volatility.